FindMyKOL
Clinical trialNCT05427214CompletedInterventional

Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy

NCT05427214 is an interventional trial sponsored by Washington University School of Medicine. As of 21 Nov 2026, it is completed. It studies Brain Cancer, Colon Cancer and 4 more conditions. The registry lists an enrollment of 52 participants at 1 site in 1 country. The registry lists a start date of 19 Aug 2022 and a primary completion date of 17 Oct 2024. One of its registered investigators has a FindMyKOL profile.

SponsorWashington University School of Medicine →Enrollment52Brain CancerColon CancerGastric CancerHead and Neck CancerLung CancerOvarian Cancer
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT05427214
FieldValue
Registry IDNCT05427214
StatusCompleted
Study typeInterventional trial
Lead sponsorWashington University School of Medicine
Enrollment52
Registered sites1
Countries1
ConditionsBrain Cancer, Colon Cancer, Gastric Cancer, Head and Neck Cancer, Lung Cancer, and Ovarian Cancer
Start19 Aug 2022
Primary completion17 Oct 2024
Study completion17 Oct 2024
Last update posted21 Oct 2024

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This prospective imaging study is evaluating the feasibility of using the Halcyon 4.0 radiotherapy system for radiation therapy planning in patients with cancer. The Halcyon 4.0 system has been engineered to decrease the image acquisition time and the radiation exposure, but the system has not yet been clinically validated for use in radiation planning. This pilot study will evaluate images obtained on the Halcyon 4.0 system to assess if the quality is sufficient for radiation treatment plan construction.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Missouri, United States1 site
  • Washington University School of Medicine

    St Louis

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouri: 1 siteMO1KentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT05427214

Each answer restates registry values shown on this page.

What is NCT05427214?

NCT05427214 is an interventional trial sponsored by Washington University School of Medicine. It studies Brain Cancer, Colon Cancer and 4 more conditions.

Who leads NCT05427214?

The registry names Pamela Samson, M.D., MPHS (principal investigator, Washington University School of Medicine) as the overall official.

Where does NCT05427214 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT05427214 end?

The registry lists a primary completion date of 17 Oct 2024 and a study completion date of 17 Oct 2024. The sponsor last updated the record on 21 Oct 2024.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.